nodes	percent_of_prediction	percent_of_DWPC	metapath
Paricalcitol—UGT1A4—Nicotine Metabolism—FMO3—metabolic syndrome X	0.0799	0.113	CbGpPWpGaD
Paricalcitol—UGT1A4—Tamoxifen metabolism—FMO3—metabolic syndrome X	0.0293	0.0414	CbGpPWpGaD
Paricalcitol—Taste metallic—Metformin—metabolic syndrome X	0.0286	0.0978	CcSEcCtD
Paricalcitol—VDR—Drug Induction of Bile Acid Pathway—NR1I3—metabolic syndrome X	0.0246	0.0347	CbGpPWpGaD
Paricalcitol—VDR—RXR and RAR heterodimerization with other nuclear receptor—NR1H3—metabolic syndrome X	0.0239	0.0338	CbGpPWpGaD
Paricalcitol—CYP24A1—Nuclear Receptors in Lipid Metabolism and Toxicity—NR1H3—metabolic syndrome X	0.023	0.0325	CbGpPWpGaD
Paricalcitol—VDR—Drug Induction of Bile Acid Pathway—NR1I2—metabolic syndrome X	0.0225	0.0318	CbGpPWpGaD
Paricalcitol—VDR—Nuclear Receptors in Lipid Metabolism and Toxicity—NR1H3—metabolic syndrome X	0.0193	0.0273	CbGpPWpGaD
Paricalcitol—VDR—Nuclear Receptors—NR1H3—metabolic syndrome X	0.0177	0.0249	CbGpPWpGaD
Paricalcitol—CYP24A1—Metabolism of steroid hormones and vitamin D—HSD11B1—metabolic syndrome X	0.0173	0.0244	CbGpPWpGaD
Paricalcitol—CYP24A1—Nuclear Receptors in Lipid Metabolism and Toxicity—NR1I3—metabolic syndrome X	0.0169	0.0238	CbGpPWpGaD
Paricalcitol—CYP24A1—Nuclear Receptors in Lipid Metabolism and Toxicity—NR1I2—metabolic syndrome X	0.0154	0.0218	CbGpPWpGaD
Paricalcitol—UGT1A4—Constitutive Androstane Receptor Pathway—NR1I3—metabolic syndrome X	0.0141	0.02	CbGpPWpGaD
Paricalcitol—VDR—Nuclear Receptors in Lipid Metabolism and Toxicity—NR1I3—metabolic syndrome X	0.0141	0.0199	CbGpPWpGaD
Paricalcitol—VDR—Nuclear Receptor transcription pathway—NR1H3—metabolic syndrome X	0.0139	0.0197	CbGpPWpGaD
Paricalcitol—VDR—Retinoic acid receptors-mediated signaling—HDAC3—metabolic syndrome X	0.0136	0.0192	CbGpPWpGaD
Paricalcitol—VDR—Nuclear Receptors—NR1I3—metabolic syndrome X	0.0129	0.0182	CbGpPWpGaD
Paricalcitol—VDR—Nuclear Receptors in Lipid Metabolism and Toxicity—NR1I2—metabolic syndrome X	0.0129	0.0182	CbGpPWpGaD
Paricalcitol—CYP24A1—Phase 1 - Functionalization of compounds—FMO3—metabolic syndrome X	0.0128	0.0181	CbGpPWpGaD
Paricalcitol—VDR—Nuclear Receptors—NR1I2—metabolic syndrome X	0.0118	0.0167	CbGpPWpGaD
Paricalcitol—Fungal infection—Metformin—metabolic syndrome X	0.0118	0.0403	CcSEcCtD
Paricalcitol—Rhinorrhoea—Metformin—metabolic syndrome X	0.0112	0.0384	CcSEcCtD
Paricalcitol—VDR—RXR and RAR heterodimerization with other nuclear receptor—SREBF1—metabolic syndrome X	0.0106	0.015	CbGpPWpGaD
Paricalcitol—Chest discomfort—Metformin—metabolic syndrome X	0.0103	0.0351	CcSEcCtD
Paricalcitol—VDR—Nuclear Receptor transcription pathway—NR1I3—metabolic syndrome X	0.0102	0.0144	CbGpPWpGaD
Paricalcitol—VDR—Nuclear Receptor transcription pathway—NR1I2—metabolic syndrome X	0.00934	0.0132	CbGpPWpGaD
Paricalcitol—VDR—RXR and RAR heterodimerization with other nuclear receptor—ABCA1—metabolic syndrome X	0.00919	0.013	CbGpPWpGaD
Paricalcitol—CYP24A1—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCA1—metabolic syndrome X	0.00885	0.0125	CbGpPWpGaD
Paricalcitol—Lightheadedness—Metformin—metabolic syndrome X	0.00812	0.0278	CcSEcCtD
Paricalcitol—CYP3A4—Liver X Receptor Pathway—NR1H3—metabolic syndrome X	0.00795	0.0112	CbGpPWpGaD
Paricalcitol—VDR—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCA1—metabolic syndrome X	0.00742	0.0105	CbGpPWpGaD
Paricalcitol—CYP3A4—Liver X Receptor Pathway—SCD—metabolic syndrome X	0.00702	0.00992	CbGpPWpGaD
Paricalcitol—CYP24A1—Biological oxidations—FMO3—metabolic syndrome X	0.00682	0.00963	CbGpPWpGaD
Paricalcitol—Hypoglycaemia—Metformin—metabolic syndrome X	0.00675	0.0231	CcSEcCtD
Paricalcitol—CYP24A1—Metapathway biotransformation—FMO3—metabolic syndrome X	0.00673	0.0095	CbGpPWpGaD
Paricalcitol—VDR—RXR and RAR heterodimerization with other nuclear receptor—PPARA—metabolic syndrome X	0.00637	0.009	CbGpPWpGaD
Paricalcitol—CYP24A1—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARA—metabolic syndrome X	0.00614	0.00867	CbGpPWpGaD
Paricalcitol—Dehydration—Metformin—metabolic syndrome X	0.00613	0.021	CcSEcCtD
Paricalcitol—CYP24A1—Metapathway biotransformation—EPHX2—metabolic syndrome X	0.006	0.00847	CbGpPWpGaD
Paricalcitol—Breast disorder—Metformin—metabolic syndrome X	0.00596	0.0204	CcSEcCtD
Paricalcitol—Nasopharyngitis—Metformin—metabolic syndrome X	0.00589	0.0202	CcSEcCtD
Paricalcitol—Influenza—Metformin—metabolic syndrome X	0.0057	0.0195	CcSEcCtD
Paricalcitol—Pancreatitis—Metformin—metabolic syndrome X	0.00559	0.0191	CcSEcCtD
Paricalcitol—Abdominal discomfort—Metformin—metabolic syndrome X	0.00546	0.0187	CcSEcCtD
Paricalcitol—UGT1A4—Biological oxidations—FMO3—metabolic syndrome X	0.00545	0.0077	CbGpPWpGaD
Paricalcitol—UGT1A4—Metapathway biotransformation—FMO3—metabolic syndrome X	0.00538	0.0076	CbGpPWpGaD
Paricalcitol—Upper respiratory tract infection—Metformin—metabolic syndrome X	0.00529	0.0181	CcSEcCtD
Paricalcitol—VDR—RXR and RAR heterodimerization with other nuclear receptor—PPARG—metabolic syndrome X	0.00527	0.00744	CbGpPWpGaD
Paricalcitol—VDR—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARA—metabolic syndrome X	0.00514	0.00726	CbGpPWpGaD
Paricalcitol—Infestation NOS—Metformin—metabolic syndrome X	0.00508	0.0174	CcSEcCtD
Paricalcitol—Infestation—Metformin—metabolic syndrome X	0.00508	0.0174	CcSEcCtD
Paricalcitol—CYP24A1—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—metabolic syndrome X	0.00507	0.00716	CbGpPWpGaD
Paricalcitol—VDR—Nuclear Receptors—NR3C1—metabolic syndrome X	0.00502	0.00709	CbGpPWpGaD
Paricalcitol—UGT1A4—Metapathway biotransformation—EPHX2—metabolic syndrome X	0.00479	0.00677	CbGpPWpGaD
Paricalcitol—CYP3A4—Tamoxifen metabolism—FMO3—metabolic syndrome X	0.00476	0.00672	CbGpPWpGaD
Paricalcitol—VDR—Nuclear Receptors—PPARA—metabolic syndrome X	0.0047	0.00664	CbGpPWpGaD
Paricalcitol—Hypoaesthesia—Metformin—metabolic syndrome X	0.00454	0.0155	CcSEcCtD
Paricalcitol—Oedema peripheral—Metformin—metabolic syndrome X	0.00449	0.0154	CcSEcCtD
Paricalcitol—Connective tissue disorder—Metformin—metabolic syndrome X	0.00448	0.0153	CcSEcCtD
Paricalcitol—Eye disorder—Metformin—metabolic syndrome X	0.00426	0.0146	CcSEcCtD
Paricalcitol—VDR—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—metabolic syndrome X	0.00425	0.006	CbGpPWpGaD
Paricalcitol—Cardiac disorder—Metformin—metabolic syndrome X	0.00423	0.0145	CcSEcCtD
Paricalcitol—Angiopathy—Metformin—metabolic syndrome X	0.00414	0.0142	CcSEcCtD
Paricalcitol—Immune system disorder—Metformin—metabolic syndrome X	0.00412	0.0141	CcSEcCtD
Paricalcitol—Mediastinal disorder—Metformin—metabolic syndrome X	0.00411	0.0141	CcSEcCtD
Paricalcitol—Chills—Metformin—metabolic syndrome X	0.00409	0.014	CcSEcCtD
Paricalcitol—Malnutrition—Metformin—metabolic syndrome X	0.00397	0.0136	CcSEcCtD
Paricalcitol—VDR—Nuclear Receptor transcription pathway—NR3C1—metabolic syndrome X	0.00397	0.0056	CbGpPWpGaD
Paricalcitol—VDR—Nuclear Receptors—PPARG—metabolic syndrome X	0.00389	0.00549	CbGpPWpGaD
Paricalcitol—Dysgeusia—Metformin—metabolic syndrome X	0.00389	0.0133	CcSEcCtD
Paricalcitol—Muscle spasms—Metformin—metabolic syndrome X	0.00382	0.0131	CcSEcCtD
Paricalcitol—CYP3A4—Drug Induction of Bile Acid Pathway—NR1I3—metabolic syndrome X	0.00381	0.00538	CbGpPWpGaD
Paricalcitol—UGT1A4—NRF2 pathway—G6PD—metabolic syndrome X	0.00374	0.00529	CbGpPWpGaD
Paricalcitol—VDR—Nuclear Receptor transcription pathway—PPARA—metabolic syndrome X	0.00372	0.00525	CbGpPWpGaD
Paricalcitol—Ill-defined disorder—Metformin—metabolic syndrome X	0.00368	0.0126	CcSEcCtD
Paricalcitol—Malaise—Metformin—metabolic syndrome X	0.00358	0.0123	CcSEcCtD
Paricalcitol—Syncope—Metformin—metabolic syndrome X	0.00356	0.0122	CcSEcCtD
Paricalcitol—CYP3A4—Liver X Receptor Pathway—SREBF1—metabolic syndrome X	0.00353	0.00498	CbGpPWpGaD
Paricalcitol—Palpitations—Metformin—metabolic syndrome X	0.00351	0.012	CcSEcCtD
Paricalcitol—Loss of consciousness—Metformin—metabolic syndrome X	0.00349	0.0119	CcSEcCtD
Paricalcitol—CYP3A4—Drug Induction of Bile Acid Pathway—NR1I2—metabolic syndrome X	0.00348	0.00492	CbGpPWpGaD
Paricalcitol—Hypertension—Metformin—metabolic syndrome X	0.00343	0.0117	CcSEcCtD
Paricalcitol—Myalgia—Metformin—metabolic syndrome X	0.00338	0.0116	CcSEcCtD
Paricalcitol—Chest pain—Metformin—metabolic syndrome X	0.00338	0.0116	CcSEcCtD
Paricalcitol—Unspecified disorder of skin and subcutaneous tissue—Metformin—metabolic syndrome X	0.00336	0.0115	CcSEcCtD
Paricalcitol—Discomfort—Metformin—metabolic syndrome X	0.00334	0.0114	CcSEcCtD
Paricalcitol—Oedema—Metformin—metabolic syndrome X	0.00324	0.0111	CcSEcCtD
Paricalcitol—Infection—Metformin—metabolic syndrome X	0.00322	0.011	CcSEcCtD
Paricalcitol—UGT1A4—Phase II conjugation—GGT1—metabolic syndrome X	0.0032	0.00452	CbGpPWpGaD
Paricalcitol—Shock—Metformin—metabolic syndrome X	0.00319	0.0109	CcSEcCtD
Paricalcitol—Nervous system disorder—Metformin—metabolic syndrome X	0.00318	0.0109	CcSEcCtD
Paricalcitol—Skin disorder—Metformin—metabolic syndrome X	0.00315	0.0108	CcSEcCtD
Paricalcitol—Hyperhidrosis—Metformin—metabolic syndrome X	0.00313	0.0107	CcSEcCtD
Paricalcitol—Anorexia—Metformin—metabolic syndrome X	0.00309	0.0106	CcSEcCtD
Paricalcitol—VDR—Nuclear Receptor transcription pathway—PPARG—metabolic syndrome X	0.00307	0.00434	CbGpPWpGaD
Paricalcitol—Hypotension—Metformin—metabolic syndrome X	0.00303	0.0104	CcSEcCtD
Paricalcitol—VDR—RXR and RAR heterodimerization with other nuclear receptor—TGFB1—metabolic syndrome X	0.003	0.00423	CbGpPWpGaD
Paricalcitol—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—NR1H3—metabolic syndrome X	0.00299	0.00422	CbGpPWpGaD
Paricalcitol—Musculoskeletal discomfort—Metformin—metabolic syndrome X	0.00295	0.0101	CcSEcCtD
Paricalcitol—Paraesthesia—Metformin—metabolic syndrome X	0.00291	0.00996	CcSEcCtD
Paricalcitol—Dyspnoea—Metformin—metabolic syndrome X	0.00289	0.00989	CcSEcCtD
Paricalcitol—Somnolence—Metformin—metabolic syndrome X	0.00288	0.00986	CcSEcCtD
Paricalcitol—Dyspepsia—Metformin—metabolic syndrome X	0.00285	0.00976	CcSEcCtD
Paricalcitol—Decreased appetite—Metformin—metabolic syndrome X	0.00282	0.00964	CcSEcCtD
Paricalcitol—VDR—RXR and RAR heterodimerization with other nuclear receptor—TNF—metabolic syndrome X	0.0028	0.00395	CbGpPWpGaD
Paricalcitol—Gastrointestinal disorder—Metformin—metabolic syndrome X	0.0028	0.00958	CcSEcCtD
Paricalcitol—Fatigue—Metformin—metabolic syndrome X	0.00279	0.00956	CcSEcCtD
Paricalcitol—Constipation—Metformin—metabolic syndrome X	0.00277	0.00948	CcSEcCtD
Paricalcitol—VDR—Regulation of nuclear SMAD2/3 signaling—NR3C1—metabolic syndrome X	0.00274	0.00387	CbGpPWpGaD
Paricalcitol—Feeling abnormal—Metformin—metabolic syndrome X	0.00267	0.00914	CcSEcCtD
Paricalcitol—Gastrointestinal pain—Metformin—metabolic syndrome X	0.00265	0.00907	CcSEcCtD
Paricalcitol—Urticaria—Metformin—metabolic syndrome X	0.00257	0.00881	CcSEcCtD
Paricalcitol—Abdominal pain—Metformin—metabolic syndrome X	0.00256	0.00877	CcSEcCtD
Paricalcitol—VDR—Generic Transcription Pathway—NR1H3—metabolic syndrome X	0.00241	0.0034	CbGpPWpGaD
Paricalcitol—CYP24A1—Biological oxidations—GGT1—metabolic syndrome X	0.00234	0.00331	CbGpPWpGaD
Paricalcitol—CYP24A1—Metabolism of lipids and lipoproteins—EPHX2—metabolic syndrome X	0.00233	0.0033	CbGpPWpGaD
Paricalcitol—Asthenia—Metformin—metabolic syndrome X	0.00232	0.00796	CcSEcCtD
Paricalcitol—CYP3A4—Constitutive Androstane Receptor Pathway—NR1I3—metabolic syndrome X	0.0023	0.00324	CbGpPWpGaD
Paricalcitol—Pruritus—Metformin—metabolic syndrome X	0.00229	0.00785	CcSEcCtD
Paricalcitol—Diarrhoea—Metformin—metabolic syndrome X	0.00222	0.00759	CcSEcCtD
Paricalcitol—UGT1A4—NRF2 pathway—SLC2A4—metabolic syndrome X	0.00221	0.00312	CbGpPWpGaD
Paricalcitol—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—NR1I3—metabolic syndrome X	0.00219	0.00309	CbGpPWpGaD
Paricalcitol—Dizziness—Metformin—metabolic syndrome X	0.00214	0.00733	CcSEcCtD
Paricalcitol—UGT1A4—NRF2 pathway—GGT1—metabolic syndrome X	0.00214	0.00302	CbGpPWpGaD
Paricalcitol—Vomiting—Metformin—metabolic syndrome X	0.00206	0.00705	CcSEcCtD
Paricalcitol—Rash—Metformin—metabolic syndrome X	0.00204	0.00699	CcSEcCtD
Paricalcitol—Dermatitis—Metformin—metabolic syndrome X	0.00204	0.00699	CcSEcCtD
Paricalcitol—Headache—Metformin—metabolic syndrome X	0.00203	0.00695	CcSEcCtD
Paricalcitol—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—NR1I2—metabolic syndrome X	0.002	0.00283	CbGpPWpGaD
Paricalcitol—Nausea—Metformin—metabolic syndrome X	0.00192	0.00659	CcSEcCtD
Paricalcitol—VDR—Regulation of nuclear SMAD2/3 signaling—SERPINE1—metabolic syndrome X	0.00191	0.0027	CbGpPWpGaD
Paricalcitol—UGT1A4—Biological oxidations—GGT1—metabolic syndrome X	0.00187	0.00265	CbGpPWpGaD
Paricalcitol—CYP24A1—Metabolism of lipids and lipoproteins—FABP4—metabolic syndrome X	0.00187	0.00264	CbGpPWpGaD
Paricalcitol—VDR—Retinoic acid receptors-mediated signaling—AKT1—metabolic syndrome X	0.00186	0.00262	CbGpPWpGaD
Paricalcitol—UGT1A4—Aryl Hydrocarbon Receptor Pathway—TGFB1—metabolic syndrome X	0.00181	0.00256	CbGpPWpGaD
Paricalcitol—CYP3A4—Aflatoxin activation and detoxification—GGT1—metabolic syndrome X	0.00177	0.0025	CbGpPWpGaD
Paricalcitol—CYP24A1—Metabolism of lipids and lipoproteins—HSD11B1—metabolic syndrome X	0.00177	0.0025	CbGpPWpGaD
Paricalcitol—VDR—Generic Transcription Pathway—NR1I3—metabolic syndrome X	0.00176	0.00249	CbGpPWpGaD
Paricalcitol—UGT1A4—Aryl Hydrocarbon Receptor Pathway—TNF—metabolic syndrome X	0.00169	0.00239	CbGpPWpGaD
Paricalcitol—CYP3A4—Phase 1 - Functionalization of compounds—FMO3—metabolic syndrome X	0.00167	0.00235	CbGpPWpGaD
Paricalcitol—VDR—Generic Transcription Pathway—NR1I2—metabolic syndrome X	0.00161	0.00228	CbGpPWpGaD
Paricalcitol—VDR—Gene Expression—EDC4—metabolic syndrome X	0.00159	0.00225	CbGpPWpGaD
Paricalcitol—CYP24A1—Metabolism of lipids and lipoproteins—HDAC3—metabolic syndrome X	0.00154	0.00217	CbGpPWpGaD
Paricalcitol—CYP24A1—Metabolism of lipids and lipoproteins—LPA—metabolic syndrome X	0.0015	0.00212	CbGpPWpGaD
Paricalcitol—CYP24A1—Metabolism of lipids and lipoproteins—PLA2G6—metabolic syndrome X	0.00146	0.00206	CbGpPWpGaD
Paricalcitol—CYP24A1—Metabolism of lipids and lipoproteins—APOA5—metabolic syndrome X	0.00144	0.00204	CbGpPWpGaD
Paricalcitol—CYP24A1—Metabolism of lipids and lipoproteins—TRIB3—metabolic syndrome X	0.00134	0.00189	CbGpPWpGaD
Paricalcitol—VDR—Direct p53 effectors—SERPINE1—metabolic syndrome X	0.00123	0.00174	CbGpPWpGaD
Paricalcitol—CYP24A1—Metabolism of lipids and lipoproteins—LIPC—metabolic syndrome X	0.00119	0.00169	CbGpPWpGaD
Paricalcitol—CYP24A1—Metabolism of lipids and lipoproteins—APOC3—metabolic syndrome X	0.00119	0.00168	CbGpPWpGaD
Paricalcitol—CYP24A1—Metabolism—FMO3—metabolic syndrome X	0.00117	0.00165	CbGpPWpGaD
Paricalcitol—VDR—Gene Expression—NR1H3—metabolic syndrome X	0.00116	0.00164	CbGpPWpGaD
Paricalcitol—CYP24A1—Metabolism of lipids and lipoproteins—CETP—metabolic syndrome X	0.00115	0.00163	CbGpPWpGaD
Paricalcitol—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCA1—metabolic syndrome X	0.00115	0.00162	CbGpPWpGaD
Paricalcitol—CYP24A1—Metabolism of lipids and lipoproteins—SCARB1—metabolic syndrome X	0.0011	0.00156	CbGpPWpGaD
Paricalcitol—CYP24A1—Metabolism of lipids and lipoproteins—SREBF1—metabolic syndrome X	0.00107	0.00151	CbGpPWpGaD
Paricalcitol—CYP24A1—Metabolism of lipids and lipoproteins—HMGCR—metabolic syndrome X	0.00104	0.00147	CbGpPWpGaD
Paricalcitol—CYP24A1—Metabolism—MLXIPL—metabolic syndrome X	0.00104	0.00147	CbGpPWpGaD
Paricalcitol—CYP24A1—Metabolism—EPHX2—metabolic syndrome X	0.00104	0.00147	CbGpPWpGaD
Paricalcitol—CYP24A1—Metabolism—G6PC2—metabolic syndrome X	0.000977	0.00138	CbGpPWpGaD
Paricalcitol—UGT1A4—Metabolism—FMO3—metabolic syndrome X	0.000932	0.00132	CbGpPWpGaD
Paricalcitol—CYP24A1—Metabolism of lipids and lipoproteins—ABCA1—metabolic syndrome X	0.000929	0.00131	CbGpPWpGaD
Paricalcitol—CYP24A1—Metabolism of lipids and lipoproteins—GGT1—metabolic syndrome X	0.0009	0.00127	CbGpPWpGaD
Paricalcitol—CYP3A4—Biological oxidations—FMO3—metabolic syndrome X	0.000885	0.00125	CbGpPWpGaD
Paricalcitol—CYP3A4—Metapathway biotransformation—FMO3—metabolic syndrome X	0.000873	0.00123	CbGpPWpGaD
Paricalcitol—VDR—Gene Expression—NR1I3—metabolic syndrome X	0.000849	0.0012	CbGpPWpGaD
Paricalcitol—VDR—Regulation of nuclear SMAD2/3 signaling—AKT1—metabolic syndrome X	0.000839	0.00119	CbGpPWpGaD
Paricalcitol—CYP24A1—Metabolism—FABP4—metabolic syndrome X	0.000831	0.00117	CbGpPWpGaD
Paricalcitol—UGT1A4—Metabolism—MLXIPL—metabolic syndrome X	0.000831	0.00117	CbGpPWpGaD
Paricalcitol—UGT1A4—Metabolism—EPHX2—metabolic syndrome X	0.000831	0.00117	CbGpPWpGaD
Paricalcitol—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARA—metabolic syndrome X	0.000796	0.00112	CbGpPWpGaD
Paricalcitol—CYP24A1—Metabolism—HSD11B1—metabolic syndrome X	0.000788	0.00111	CbGpPWpGaD
Paricalcitol—UGT1A4—Metabolism—G6PC2—metabolic syndrome X	0.000781	0.0011	CbGpPWpGaD
Paricalcitol—CYP3A4—Metapathway biotransformation—EPHX2—metabolic syndrome X	0.000778	0.0011	CbGpPWpGaD
Paricalcitol—VDR—Gene Expression—NR1I2—metabolic syndrome X	0.000777	0.0011	CbGpPWpGaD
Paricalcitol—CYP24A1—Metabolism of lipids and lipoproteins—APOB—metabolic syndrome X	0.000764	0.00108	CbGpPWpGaD
Paricalcitol—CYP24A1—Metabolism of lipids and lipoproteins—PLA2G4A—metabolic syndrome X	0.000743	0.00105	CbGpPWpGaD
Paricalcitol—CYP24A1—Metabolism of lipids and lipoproteins—LPL—metabolic syndrome X	0.000729	0.00103	CbGpPWpGaD
Paricalcitol—UGT1A4—NRF2 pathway—TGFB1—metabolic syndrome X	0.000719	0.00102	CbGpPWpGaD
Paricalcitol—CYP24A1—Metabolism—G6PD—metabolic syndrome X	0.000702	0.000992	CbGpPWpGaD
Paricalcitol—CYP24A1—Metabolism of lipids and lipoproteins—CD36—metabolic syndrome X	0.000693	0.000979	CbGpPWpGaD
Paricalcitol—CYP24A1—Metabolism—HDAC3—metabolic syndrome X	0.000685	0.000968	CbGpPWpGaD
Paricalcitol—VDR—Generic Transcription Pathway—NR3C1—metabolic syndrome X	0.000685	0.000968	CbGpPWpGaD
Paricalcitol—CYP24A1—Metabolism—GCKR—metabolic syndrome X	0.00067	0.000946	CbGpPWpGaD
Paricalcitol—CYP24A1—Metabolism—LPA—metabolic syndrome X	0.00067	0.000946	CbGpPWpGaD
Paricalcitol—UGT1A4—Metabolism—FABP4—metabolic syndrome X	0.000664	0.000938	CbGpPWpGaD
Paricalcitol—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—metabolic syndrome X	0.000658	0.00093	CbGpPWpGaD
Paricalcitol—CYP24A1—Metabolism—PLA2G6—metabolic syndrome X	0.000649	0.000916	CbGpPWpGaD
Paricalcitol—CYP24A1—Metabolism of lipids and lipoproteins—PPARA—metabolic syndrome X	0.000644	0.00091	CbGpPWpGaD
Paricalcitol—CYP24A1—Metabolism—APOA5—metabolic syndrome X	0.000642	0.000907	CbGpPWpGaD
Paricalcitol—VDR—Generic Transcription Pathway—PPARA—metabolic syndrome X	0.000642	0.000907	CbGpPWpGaD
Paricalcitol—UGT1A4—Metabolism—HSD11B1—metabolic syndrome X	0.00063	0.00089	CbGpPWpGaD
Paricalcitol—CYP24A1—Metabolism of lipids and lipoproteins—AGT—metabolic syndrome X	0.000624	0.000881	CbGpPWpGaD
Paricalcitol—CYP24A1—Metabolism of lipids and lipoproteins—APOE—metabolic syndrome X	0.000611	0.000863	CbGpPWpGaD
Paricalcitol—CYP24A1—Metabolism of lipids and lipoproteins—APOA1—metabolic syndrome X	0.000604	0.000854	CbGpPWpGaD
Paricalcitol—CYP24A1—Metabolism—TRIB3—metabolic syndrome X	0.000597	0.000843	CbGpPWpGaD
Paricalcitol—UGT1A4—Metabolism—G6PD—metabolic syndrome X	0.000561	0.000793	CbGpPWpGaD
Paricalcitol—UGT1A4—Metabolism—HDAC3—metabolic syndrome X	0.000548	0.000774	CbGpPWpGaD
Paricalcitol—CYP24A1—Metabolism—NAMPT—metabolic syndrome X	0.000536	0.000756	CbGpPWpGaD
Paricalcitol—UGT1A4—Metabolism—GCKR—metabolic syndrome X	0.000536	0.000756	CbGpPWpGaD
Paricalcitol—UGT1A4—Metabolism—LPA—metabolic syndrome X	0.000536	0.000756	CbGpPWpGaD
Paricalcitol—CYP24A1—Metabolism of lipids and lipoproteins—PPARG—metabolic syndrome X	0.000532	0.000752	CbGpPWpGaD
Paricalcitol—CYP24A1—Metabolism—GCK—metabolic syndrome X	0.000532	0.000752	CbGpPWpGaD
Paricalcitol—CYP24A1—Metabolism—LIPC—metabolic syndrome X	0.000532	0.000752	CbGpPWpGaD
Paricalcitol—VDR—Generic Transcription Pathway—PPARG—metabolic syndrome X	0.000531	0.00075	CbGpPWpGaD
Paricalcitol—CYP24A1—Metabolism—APOC3—metabolic syndrome X	0.000529	0.000747	CbGpPWpGaD
Paricalcitol—UGT1A4—Metabolism—PLA2G6—metabolic syndrome X	0.000519	0.000733	CbGpPWpGaD
Paricalcitol—UGT1A4—Metabolism—APOA5—metabolic syndrome X	0.000513	0.000725	CbGpPWpGaD
Paricalcitol—CYP24A1—Metabolism—CETP—metabolic syndrome X	0.000513	0.000725	CbGpPWpGaD
Paricalcitol—CYP24A1—Metabolism—SCARB1—metabolic syndrome X	0.000492	0.000695	CbGpPWpGaD
Paricalcitol—CYP24A1—Metabolism of lipids and lipoproteins—ALB—metabolic syndrome X	0.000479	0.000676	CbGpPWpGaD
Paricalcitol—VDR—Generic Transcription Pathway—SERPINE1—metabolic syndrome X	0.000478	0.000675	CbGpPWpGaD
Paricalcitol—CYP24A1—Metabolism—SREBF1—metabolic syndrome X	0.000477	0.000674	CbGpPWpGaD
Paricalcitol—UGT1A4—Metabolism—TRIB3—metabolic syndrome X	0.000477	0.000674	CbGpPWpGaD
Paricalcitol—CYP24A1—Metabolism—HMGCR—metabolic syndrome X	0.000464	0.000656	CbGpPWpGaD
Paricalcitol—CYP24A1—Metabolism—GOT2—metabolic syndrome X	0.000464	0.000656	CbGpPWpGaD
Paricalcitol—UGT1A4—Metabolism—NAMPT—metabolic syndrome X	0.000428	0.000605	CbGpPWpGaD
Paricalcitol—UGT1A4—Metabolism—LIPC—metabolic syndrome X	0.000425	0.000601	CbGpPWpGaD
Paricalcitol—UGT1A4—Metabolism—GCK—metabolic syndrome X	0.000425	0.000601	CbGpPWpGaD
Paricalcitol—UGT1A4—Metabolism—APOC3—metabolic syndrome X	0.000423	0.000597	CbGpPWpGaD
Paricalcitol—CYP24A1—Metabolism of lipids and lipoproteins—PTGS2—metabolic syndrome X	0.000419	0.000592	CbGpPWpGaD
Paricalcitol—CYP24A1—Metabolism—ABCA1—metabolic syndrome X	0.000414	0.000585	CbGpPWpGaD
Paricalcitol—CYP24A1—Metabolism—SLC2A4—metabolic syndrome X	0.000414	0.000585	CbGpPWpGaD
Paricalcitol—UGT1A4—Metabolism—CETP—metabolic syndrome X	0.00041	0.00058	CbGpPWpGaD
Paricalcitol—CYP24A1—Metabolism—GGT1—metabolic syndrome X	0.000401	0.000566	CbGpPWpGaD
Paricalcitol—CYP24A1—Metabolism—GOT1—metabolic syndrome X	0.000401	0.000566	CbGpPWpGaD
Paricalcitol—UGT1A4—Metabolism—SCARB1—metabolic syndrome X	0.000393	0.000555	CbGpPWpGaD
Paricalcitol—UGT1A4—Metabolism—SREBF1—metabolic syndrome X	0.000382	0.000539	CbGpPWpGaD
Paricalcitol—VDR—Gene Expression—SIRT1—metabolic syndrome X	0.000372	0.000525	CbGpPWpGaD
Paricalcitol—UGT1A4—Metabolism—HMGCR—metabolic syndrome X	0.000371	0.000524	CbGpPWpGaD
Paricalcitol—UGT1A4—Metabolism—GOT2—metabolic syndrome X	0.000371	0.000524	CbGpPWpGaD
Paricalcitol—CYP24A1—Metabolism—APOB—metabolic syndrome X	0.00034	0.00048	CbGpPWpGaD
Paricalcitol—UGT1A4—Metabolism—SLC2A4—metabolic syndrome X	0.000331	0.000467	CbGpPWpGaD
Paricalcitol—CYP24A1—Metabolism—PLA2G4A—metabolic syndrome X	0.000331	0.000467	CbGpPWpGaD
Paricalcitol—UGT1A4—Metabolism—ABCA1—metabolic syndrome X	0.000331	0.000467	CbGpPWpGaD
Paricalcitol—VDR—Gene Expression—NR3C1—metabolic syndrome X	0.00033	0.000466	CbGpPWpGaD
Paricalcitol—CYP24A1—Metabolism—LPL—metabolic syndrome X	0.000325	0.000459	CbGpPWpGaD
Paricalcitol—UGT1A4—Metabolism—GGT1—metabolic syndrome X	0.00032	0.000453	CbGpPWpGaD
Paricalcitol—UGT1A4—Metabolism—GOT1—metabolic syndrome X	0.00032	0.000453	CbGpPWpGaD
Paricalcitol—VDR—Gene Expression—PPARA—metabolic syndrome X	0.000309	0.000437	CbGpPWpGaD
Paricalcitol—CYP24A1—Metabolism—CD36—metabolic syndrome X	0.000309	0.000436	CbGpPWpGaD
Paricalcitol—CYP3A4—Biological oxidations—GGT1—metabolic syndrome X	0.000304	0.00043	CbGpPWpGaD
Paricalcitol—CYP24A1—Metabolism—PPARA—metabolic syndrome X	0.000287	0.000405	CbGpPWpGaD
Paricalcitol—CYP24A1—Metabolism—AGT—metabolic syndrome X	0.000278	0.000392	CbGpPWpGaD
Paricalcitol—CYP24A1—Metabolism—APOE—metabolic syndrome X	0.000272	0.000385	CbGpPWpGaD
Paricalcitol—UGT1A4—Metabolism—APOB—metabolic syndrome X	0.000272	0.000384	CbGpPWpGaD
Paricalcitol—CYP24A1—Metabolism—APOA1—metabolic syndrome X	0.000269	0.00038	CbGpPWpGaD
Paricalcitol—UGT1A4—Metabolism—PLA2G4A—metabolic syndrome X	0.000264	0.000374	CbGpPWpGaD
Paricalcitol—UGT1A4—Metabolism—LPL—metabolic syndrome X	0.00026	0.000367	CbGpPWpGaD
Paricalcitol—VDR—Gene Expression—PPARG—metabolic syndrome X	0.000256	0.000361	CbGpPWpGaD
Paricalcitol—UGT1A4—Metabolism—CD36—metabolic syndrome X	0.000247	0.000348	CbGpPWpGaD
Paricalcitol—CYP24A1—Metabolism—PPARG—metabolic syndrome X	0.000237	0.000335	CbGpPWpGaD
Paricalcitol—CYP24A1—Metabolism—INS—metabolic syndrome X	0.000233	0.000328	CbGpPWpGaD
Paricalcitol—VDR—Gene Expression—SERPINE1—metabolic syndrome X	0.00023	0.000325	CbGpPWpGaD
Paricalcitol—UGT1A4—Metabolism—PPARA—metabolic syndrome X	0.000229	0.000324	CbGpPWpGaD
Paricalcitol—UGT1A4—Metabolism—AGT—metabolic syndrome X	0.000222	0.000314	CbGpPWpGaD
Paricalcitol—UGT1A4—Metabolism—APOE—metabolic syndrome X	0.000218	0.000307	CbGpPWpGaD
Paricalcitol—UGT1A4—Metabolism—APOA1—metabolic syndrome X	0.000215	0.000304	CbGpPWpGaD
Paricalcitol—CYP24A1—Metabolism—ALB—metabolic syndrome X	0.000213	0.000301	CbGpPWpGaD
Paricalcitol—CYP24A1—Metabolism—NOS3—metabolic syndrome X	0.000204	0.000288	CbGpPWpGaD
Paricalcitol—UGT1A4—Metabolism—PPARG—metabolic syndrome X	0.00019	0.000268	CbGpPWpGaD
Paricalcitol—CYP24A1—Metabolism—PTGS2—metabolic syndrome X	0.000187	0.000263	CbGpPWpGaD
Paricalcitol—UGT1A4—Metabolism—INS—metabolic syndrome X	0.000186	0.000263	CbGpPWpGaD
Paricalcitol—UGT1A4—Metabolism—ALB—metabolic syndrome X	0.00017	0.000241	CbGpPWpGaD
Paricalcitol—UGT1A4—Metabolism—NOS3—metabolic syndrome X	0.000163	0.00023	CbGpPWpGaD
Paricalcitol—CYP3A4—Metabolism—FMO3—metabolic syndrome X	0.000151	0.000214	CbGpPWpGaD
Paricalcitol—UGT1A4—Metabolism—PTGS2—metabolic syndrome X	0.000149	0.000211	CbGpPWpGaD
Paricalcitol—CYP3A4—Metabolism—EPHX2—metabolic syndrome X	0.000135	0.000191	CbGpPWpGaD
Paricalcitol—CYP3A4—Metabolism—MLXIPL—metabolic syndrome X	0.000135	0.000191	CbGpPWpGaD
Paricalcitol—CYP3A4—Metabolism—G6PC2—metabolic syndrome X	0.000127	0.000179	CbGpPWpGaD
Paricalcitol—CYP3A4—Metabolism—FABP4—metabolic syndrome X	0.000108	0.000152	CbGpPWpGaD
Paricalcitol—CYP3A4—Metabolism—HSD11B1—metabolic syndrome X	0.000102	0.000144	CbGpPWpGaD
Paricalcitol—VDR—Gene Expression—AKT1—metabolic syndrome X	0.000101	0.000143	CbGpPWpGaD
Paricalcitol—CYP24A1—Metabolism—AKT1—metabolic syndrome X	9.37e-05	0.000132	CbGpPWpGaD
Paricalcitol—CYP3A4—Metabolism—G6PD—metabolic syndrome X	9.11e-05	0.000129	CbGpPWpGaD
Paricalcitol—CYP3A4—Metabolism—HDAC3—metabolic syndrome X	8.89e-05	0.000126	CbGpPWpGaD
Paricalcitol—CYP3A4—Metabolism—GCKR—metabolic syndrome X	8.69e-05	0.000123	CbGpPWpGaD
Paricalcitol—CYP3A4—Metabolism—LPA—metabolic syndrome X	8.69e-05	0.000123	CbGpPWpGaD
Paricalcitol—CYP3A4—Metabolism—PLA2G6—metabolic syndrome X	8.42e-05	0.000119	CbGpPWpGaD
Paricalcitol—CYP3A4—Metabolism—APOA5—metabolic syndrome X	8.33e-05	0.000118	CbGpPWpGaD
Paricalcitol—CYP3A4—Metabolism—TRIB3—metabolic syndrome X	7.75e-05	0.000109	CbGpPWpGaD
Paricalcitol—UGT1A4—Metabolism—AKT1—metabolic syndrome X	7.49e-05	0.000106	CbGpPWpGaD
Paricalcitol—CYP3A4—Metabolism—NAMPT—metabolic syndrome X	6.95e-05	9.82e-05	CbGpPWpGaD
Paricalcitol—CYP3A4—Metabolism—LIPC—metabolic syndrome X	6.91e-05	9.76e-05	CbGpPWpGaD
Paricalcitol—CYP3A4—Metabolism—GCK—metabolic syndrome X	6.91e-05	9.76e-05	CbGpPWpGaD
Paricalcitol—CYP3A4—Metabolism—APOC3—metabolic syndrome X	6.86e-05	9.69e-05	CbGpPWpGaD
Paricalcitol—CYP3A4—Metabolism—CETP—metabolic syndrome X	6.66e-05	9.41e-05	CbGpPWpGaD
Paricalcitol—CYP3A4—Metabolism—SCARB1—metabolic syndrome X	6.38e-05	9.01e-05	CbGpPWpGaD
Paricalcitol—CYP3A4—Metabolism—SREBF1—metabolic syndrome X	6.19e-05	8.75e-05	CbGpPWpGaD
Paricalcitol—CYP3A4—Metabolism—HMGCR—metabolic syndrome X	6.03e-05	8.51e-05	CbGpPWpGaD
Paricalcitol—CYP3A4—Metabolism—GOT2—metabolic syndrome X	6.03e-05	8.51e-05	CbGpPWpGaD
Paricalcitol—CYP3A4—Metabolism—ABCA1—metabolic syndrome X	5.37e-05	7.59e-05	CbGpPWpGaD
Paricalcitol—CYP3A4—Metabolism—SLC2A4—metabolic syndrome X	5.37e-05	7.59e-05	CbGpPWpGaD
Paricalcitol—CYP3A4—Metabolism—GOT1—metabolic syndrome X	5.2e-05	7.35e-05	CbGpPWpGaD
Paricalcitol—CYP3A4—Metabolism—GGT1—metabolic syndrome X	5.2e-05	7.35e-05	CbGpPWpGaD
Paricalcitol—CYP3A4—Metabolism—APOB—metabolic syndrome X	4.41e-05	6.23e-05	CbGpPWpGaD
Paricalcitol—CYP3A4—Metabolism—PLA2G4A—metabolic syndrome X	4.29e-05	6.06e-05	CbGpPWpGaD
Paricalcitol—CYP3A4—Metabolism—LPL—metabolic syndrome X	4.21e-05	5.95e-05	CbGpPWpGaD
Paricalcitol—CYP3A4—Metabolism—CD36—metabolic syndrome X	4e-05	5.66e-05	CbGpPWpGaD
Paricalcitol—CYP3A4—Metabolism—PPARA—metabolic syndrome X	3.72e-05	5.26e-05	CbGpPWpGaD
Paricalcitol—CYP3A4—Metabolism—AGT—metabolic syndrome X	3.61e-05	5.09e-05	CbGpPWpGaD
Paricalcitol—CYP3A4—Metabolism—APOE—metabolic syndrome X	3.53e-05	4.99e-05	CbGpPWpGaD
Paricalcitol—CYP3A4—Metabolism—APOA1—metabolic syndrome X	3.49e-05	4.93e-05	CbGpPWpGaD
Paricalcitol—CYP3A4—Metabolism—PPARG—metabolic syndrome X	3.08e-05	4.35e-05	CbGpPWpGaD
Paricalcitol—CYP3A4—Metabolism—INS—metabolic syndrome X	3.02e-05	4.26e-05	CbGpPWpGaD
Paricalcitol—CYP3A4—Metabolism—ALB—metabolic syndrome X	2.77e-05	3.91e-05	CbGpPWpGaD
Paricalcitol—CYP3A4—Metabolism—NOS3—metabolic syndrome X	2.65e-05	3.74e-05	CbGpPWpGaD
Paricalcitol—CYP3A4—Metabolism—PTGS2—metabolic syndrome X	2.42e-05	3.42e-05	CbGpPWpGaD
Paricalcitol—CYP3A4—Metabolism—AKT1—metabolic syndrome X	1.22e-05	1.72e-05	CbGpPWpGaD
